These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20306834)

  • 1. Breast pathology: beyond morphology.
    Simpson PT; Reis-Filho JS; Lakhani SR
    Semin Diagn Pathol; 2010 Feb; 27(1):91-6. PubMed ID: 20306834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological aspects of in situ carcinoma/intraepithelial neoplasia of the breast].
    Kulka J
    Orv Hetil; 2010 Jan; 151(2):45-53. PubMed ID: 20061232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invasive breast cancer: the current WHO classification].
    Lebeau A; Kriegsmann M; Burandt E; Sinn HP
    Pathologe; 2014 Feb; 35(1):7-17. PubMed ID: 24496990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases.
    Ross DS; Hoda SA
    Am J Surg Pathol; 2011 May; 35(5):750-6. PubMed ID: 21415700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
    Wagner PL; Kitabayashi N; Chen YT; Shin SJ
    Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
    Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
    J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular evolutionary patterns in breast cancer.
    Shackney SE; Silverman JF
    Adv Anat Pathol; 2003 Sep; 10(5):278-90. PubMed ID: 12973049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer pathology: the impact of molecular taxonomy on morphological taxonomy.
    Masuda S
    Pathol Int; 2012 May; 62(5):295-302. PubMed ID: 22524656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
    Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
    Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2004.
    Kinoshita T; Fukui N; Anan K; Iwamoto T; Niikura N; Kawai M; Hayashi N; Tsugawa K; Aogi K; Ishida T; Masuoka H; Masuda S; Iijima K; Nakamura S; Tokuda Y
    Breast Cancer; 2016 Jan; 23(1):39-49. PubMed ID: 26446041
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.
    Ottesen GL; Christensen IJ; Larsen JK; Larsen J; Baldetorp B; Linden T; Hansen B; Andersen J
    Breast Cancer Res Treat; 2000 Apr; 60(3):219-26. PubMed ID: 10930109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogenetic analysis of combined lobular and ductal carcinoma of the breast.
    Kobayashi H; Nakai T; Nakanishi Y; Esumi M; Masuda S
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobular breast carcinoma and its variants.
    Rakha EA; Ellis IO
    Semin Diagn Pathol; 2010 Feb; 27(1):49-61. PubMed ID: 20306830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
    Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
    Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
    Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.